Patent classifications
A61M16/10
Universal respiratory detector
A universal respiratory detector for detecting a respiratory gas. The universal respiratory detector may include a plurality of layers with a visual indicator to quickly and reversibly change color to detect a respiratory gas parameter such as carbon dioxide. The color change may be visible from both sides of the detector. In some examples, the respiratory detector may be a biocompatible and conformable sticker for mounting on a person's face or an oxygen delivery device.
Heat and moisture exchanger for a patient interface
A patient interface for supplying a flow of breathable gas to the airways of a patient may comprise a heat and moisture exchanger (HME). The HME may be positioned in a flow path of the flow of breathable gas. The HME may absorb heat and moisture from gas exhaled by the patient and the incoming flow of breathable gas to be supplied to the patient's airways may be heated and moisturized by the heat and moisture held in the HME.
Systems and methods for ambulatory generation of nitric oxide
Systems and methods are provided for portable and compact nitric oxide (NO) generation that can be embedded into other therapeutic devices or used alone. In some embodiments, an ambulatory NO generation system can be comprised of a controller and disposable cartridge. The cartridge can contain filters and scavengers for preparing the gas used for NO generation and for scrubbing output gases prior to patient inhalation. The system can utilize an oxygen concentrator to increase nitric oxide production and compliment oxygen generator activity as an independent device. The system can also include a high voltage electrode assembly that is easily assembled and installed. Various nitric oxide delivery methods are provided, including the use of a nasal cannula.
Systems and methods for manufacturing and safety of an NO.SUB.2.-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient
The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO.sub.2 to NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide systems and methods of determining the remaining useful life of a NO.sub.2-to-NO reactor cartridge and/or a breakthrough of NO.sub.2, and providing an indication of the remaining useful life and/or breakthrough.
Apparatus and method for detecting liquid level in a clear or partially clear container
A trap bowl is provided to accumulate liquid droplets from a filter, as a liquid content. The trap bowl includes a transparent vertical prism. The transparent vertical prism includes a face that forms a vertical transparent surface facing against a content of the section. The face can provide a first angle of total reflection when content of the section is a type of gas, and a second angle of total reflection when the content of the section is the liquid content. A light source may emit a light beam incident on the face at an angle of incidence. The angle of incidence results in reflection of the light beam, striking the light receiver, when the face has the first angle of total reflection, and results in refraction of the light beam, missing the light receiver, when the face has the second angle of total reflection.
Manual resuscitation bag with improved PEP exhaust valve
The invention concerns a manual resuscitation bag having a first PEP exhaust valve (4) arranged in a first conduit element (3) and fluidly communicating with the ambient atmosphere for venting gas to the atmosphere when the gas pressure, into the first conduit element (3), exceeds a given pressure threshold. The first PEP exhaust valve (4) has a valve body (5) and a calibration mechanism (6, 12; 7-10) for setting a desired pressure threshold. The calibration mechanism (6, 12; 7-10) is a rotatable member (6), actuatable by a user, arranged on the valve body (5) and cooperating with a pressure adjusting device (7-10) arranged into the valve body (5), and a support member (12) comprising several markings (11) corresponding to several settable pressure values, arranged between the rotatable member (6) and the valve body (5).
BREATHING ASSISTANCE APPARATUS
A CPAP system for supplying humidified gases to a user is disclosed in which various interfaces are described for gas delivery. A mask cushion including a deformable cushion and thin sheath is described.
HUMIDIFICATION DEVICE, HUMIDIFIER AND VENTILATOR
The present disclosure discloses a humidification device, a humidifier and a ventilator, overcoming the deficiency that when the structure of a water tank of a current ventilator causes the water tank to tilt or sway, it is easy for a large amount of water to enter a heating portion. The humidification device comprises a heating portion and a liquid inlet structure adding liquid to the heating portion. The heating portion comprises an accommodating chamber and a transition chamber limiting the amount of liquid in the accommodating chamber, and the liquid inlet structure is communicated with the transition chamber and allows the liquid to enter the transition chamber. According to embodiments of the present disclosure, a large amount of stored water may be prevented from entering the heating portion and thus affecting the heating efficiency when a water tank or a similar humidification device tilts.
SYSTEMS ANDMETHODS TO IMPROVE ORGANOR TISSUE FUNCTION ANDORGANOR TISSUE TRANSPLANT LONGEVITY
The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack.
SYSTEMS ANDMETHODS TO IMPROVE ORGANOR TISSUE FUNCTION ANDORGANOR TISSUE TRANSPLANT LONGEVITY
The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack.